Israeli developer of noninvasive medical devices for the treatment of neurological and psychopathological disorders, Brainsway, announced positive results in its trial for the treatment of severe depression. The treatment, which uses a Deep Transcranial Magnetic Stimulation (TMS) device, was found to be effective and safe – company announced. The trial included 250 patients and showed improvements among those treated with Deep TMS compared to the control group, based on the Hamilton Depression Rating Scale.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

AI Startup Helps Doctors Analyze Heart Scans
February 08, 2023

AI Monitors High-Speed Conveyor Belts For Defects
February 08, 2023

Israel Hi-Tech Group In Rescue Mission To Turkey
February 08, 2023

Israeli Startup Tests Cancer Treatment With Pharma Giant
February 07, 2023
Facebook comments